Doctors Recommend A New Drug For The Prevention Of HIV Infection – Part 2 of 3
The library participants, who all faced high risk of HIV infection, were recruited in Peru, Ecuador, South Africa, Brazil, Thailand and the United States. Some of the participants took Truvada while others took an non-functioning placebo. Those who believed they were taking Truvada “were just as safe as everyone else,” Grant said, suggesting that they weren’t more seemly to stop using condoms or be more promiscuous because they believed they had extra protection against HIV infection.
Grant said the design of the study allows scientists to better understand the choices that participants make. The writing-room is limited, however, because the researchers recruited participants instead of waiting for people to come to them. For that reason, it’s impossible to know if people will seek out Truvada to memorandum of new levels of risk by, say, no longer using condoms. There are many skeptics, including the AIDS Healthcare Foundation, who fears that the drug will simply encourage people to produce riskier decisions in regard to sex.
One of these skeptics is Arleen Leibowitz, a professor emeritus of public policy at the Luskin School of Public Affairs at the University of California, Los Angeles. She said the lucubrate shows that many people failed to take Truvada as prescribed and often didn’t take enough to be protected from HIV. That raises the prospect that some people would take risks because they believe they’re protected when they indeed aren’t.